pubmed-article:12642425 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12642425 | lifeskim:mentions | umls-concept:C0019163 | lld:lifeskim |
pubmed-article:12642425 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
pubmed-article:12642425 | lifeskim:mentions | umls-concept:C1444711 | lld:lifeskim |
pubmed-article:12642425 | lifeskim:mentions | umls-concept:C0042196 | lld:lifeskim |
pubmed-article:12642425 | lifeskim:mentions | umls-concept:C0600367 | lld:lifeskim |
pubmed-article:12642425 | lifeskim:mentions | umls-concept:C2745888 | lld:lifeskim |
pubmed-article:12642425 | lifeskim:mentions | umls-concept:C0006193 | lld:lifeskim |
pubmed-article:12642425 | lifeskim:mentions | umls-concept:C0175671 | lld:lifeskim |
pubmed-article:12642425 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:12642425 | pubmed:dateCreated | 2003-3-18 | lld:pubmed |
pubmed-article:12642425 | pubmed:abstractText | Countries with a low risk of hepatitis B (HB) lack data on the effectiveness of universal HB vaccination programs for children. British Columbia began a program in 1992, offering HB vaccination to 11 year olds. We conducted an anonymous, unlinked serologic survey 7 years later, analyzing a random sample of specimens (n = 1215) from women aged 15-44 years who had undergone antenatal rubella testing. Among those aged 15-19 years inclusive there was no evidence of chronic HB (HB surface antigen), the proportion with evidence of acute HB (anti-HB core antibody) was only 0.6% (compared with 6.5% for the entire sample), and evidence of protective immunity was strong: the prevalence of anti-HB surface antibody (anti-HBs) was 79.1% (compared with 41.4% for the entire sample) and the geometric mean titre was 34.9 IU/mL (compared with 0.6-0.8 IU/mL for the older groups [p < 0.001]). | lld:pubmed |
pubmed-article:12642425 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12642425 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12642425 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12642425 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12642425 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12642425 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12642425 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12642425 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12642425 | pubmed:language | eng | lld:pubmed |
pubmed-article:12642425 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12642425 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:12642425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12642425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12642425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12642425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12642425 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12642425 | pubmed:month | Mar | lld:pubmed |
pubmed-article:12642425 | pubmed:issn | 0820-3946 | lld:pubmed |
pubmed-article:12642425 | pubmed:author | pubmed-author:DawarMeenaksh... | lld:pubmed |
pubmed-article:12642425 | pubmed:author | pubmed-author:PatrickDavid... | lld:pubmed |
pubmed-article:12642425 | pubmed:author | pubmed-author:KrajdenMelM | lld:pubmed |
pubmed-article:12642425 | pubmed:author | pubmed-author:CookDarrelD | lld:pubmed |
pubmed-article:12642425 | pubmed:author | pubmed-author:BighamMarkM | lld:pubmed |
pubmed-article:12642425 | pubmed:author | pubmed-author:NgHelenH | lld:pubmed |
pubmed-article:12642425 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12642425 | pubmed:day | 18 | lld:pubmed |
pubmed-article:12642425 | pubmed:volume | 168 | lld:pubmed |
pubmed-article:12642425 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12642425 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12642425 | pubmed:pagination | 703-4 | lld:pubmed |
pubmed-article:12642425 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:meshHeading | pubmed-meshheading:12642425... | lld:pubmed |
pubmed-article:12642425 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12642425 | pubmed:articleTitle | Impact of universal preadolescent vaccination against hepatitis B on antenatal seroprevalence of hepatitis B markers in British Columbia women. | lld:pubmed |
pubmed-article:12642425 | pubmed:affiliation | First Nations and Inuit Health Branch, Medical Programs, Pacific Region, Health Canada, Vancouver, BC. meenakshi_dawar@hc-sc.gc.ca | lld:pubmed |
pubmed-article:12642425 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12642425 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12642425 | lld:pubmed |